What is the growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the market?

Key drivers include rising healthcare costs and the need for non-invasive screening methods.

What challenges does the market face?

Challenges include high development costs and regulatory hurdles.

Which regions are leaders in the market?

North America and Europe are regional leaders, due to high healthcare expenditure.

Who are the top companies in the market?

Top companies include Medtronic, Philips, and Siemens, which offer innovative solutions.

What future opportunities exist in the market?

Future opportunities include emerging markets and technological advancements.

How will technology impact the market?

Advances in technology will improve accuracy and efficiency of Non-invasive Parenteral Screening Instruments.

What is the regulatory landscape for the market?

The regulatory landscape is complex, with stringent regulations governing medical devices.

What is the future outlook for the market?

The future outlook is positive, with increasing adoption of non-invasive screening methods.

Non-invasive Parenteral Screening Instruments Market Growing at CAGR — 2026 Report

Non-invasive Parenteral Screening Instruments by Application (Diagnostic Laboratories, Hospitals), by Types (Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-invasive Parenteral Screening Instruments Market Overview

The Non-invasive Parenteral Screening Instruments market refers to the industry that provides devices and technologies for the non-invasive screening of parenteral samples. As the Non-invasive Parenteral Screening Instruments market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a promising industry expansion driven by advancements in technology and increasing demand for non-invasive screening methods. The scope of this market encompasses various synonyms such as non-invasive parenteral testing, point-of-care diagnostics, and in-vitro diagnostics.

Loading chart…

The current Non-invasive Parenteral Screening Instruments market size is expected to grow at a CAGR of 8.5% during the forecast period from 2026 to 2033, driven by macro drivers such as the increasing prevalence of chronic diseases, rising demand for point-of-care diagnostics, and advancements in technology. Key forces shaping the industry include technology shifts towards non-invasive and point-of-care diagnostics, regulations supporting the adoption of non-invasive screening methods, and consumer behavior driving the demand for convenient and pain-free screening methods. The largest region in the Non-invasive Parenteral Screening Instruments market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing adoption of non-invasive screening methods in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	12.87 million
Growth rate	CAGR of 0.065% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Philips; Illumina; Thermo Fisher Scientific; Roche; PacBio; Perkinelmer; Qiagen; Agilent Technologies; BGI Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-invasive Parenteral Screening Instruments market is experiencing significant growth, driven by various factors that are shaping its landscape. This section provides an in-depth analysis of the market dynamics, highlighting the key drivers, restraints, opportunities, and challenges that are influencing the Non-invasive Parenteral Screening Instruments market size and growth forecast.

Growth Drivers2 items

Increasing demand for non-invasive diagnostic techniques is driving the adoption of Non-invasive Parenteral Screening Instruments, particularly in the healthcare sector, where patient comfort and safety are paramount.

Advances in technology, such as the development of portable and handheld devices, are expanding the reach of Non-invasive Parenteral Screening Instruments and contributing to the growth of the Non-invasive Parenteral Screening Instruments market.

Restraints2 items

High cost of Non-invasive Parenteral Screening Instruments, particularly advanced devices, is limiting their adoption in resource-constrained settings and hindering the growth of the Non-invasive Parenteral Screening Instruments market size.

Stringent regulatory requirements and the need for FDA clearance are creating barriers to entry for new players and slowing down the growth forecast of the Non-invasive Parenteral Screening Instruments market.

Opportunities2 items

Growing awareness about the importance of early disease detection is creating opportunities for Non-invasive Parenteral Screening Instruments manufacturers to develop innovative solutions that cater to the needs of high-risk patients.

Increasing adoption of telemedicine and remote patient monitoring is expanding the potential applications of Non-invasive Parenteral Screening Instruments and driving growth in the Non-invasive Parenteral Screening Instruments market.

Challenges2 items

Intense competition in the Non-invasive Parenteral Screening Instruments market is driving down prices and reducing profit margins for manufacturers, making it challenging to sustain growth and invest in research and development.

Managing supply chain disruptions and ensuring the quality of Non-invasive Parenteral Screening Instruments is a significant challenge, particularly in the face of global demand fluctuations and regulatory changes.

Market Segmentation

Loading chart…

The Non-invasive Parenteral Screening Instruments market can be segmented based on Application, which refers to the specific use cases of these instruments. This segmentation category contributes to the overall market size by highlighting the various industries and fields that utilize non-invasive parenteral screening instruments. The application segment includes subtypes such as disease diagnosis and patient monitoring, which are critical components of the Non-invasive Parenteral Screening Instruments segmentation.

Another significant segmentation category in the Non-invasive Parenteral Screening Instruments market is Types, which encompasses various subtypes of instruments. These subtypes include [object Object] and [object Object], each with its unique characteristics, advantages, and limitations. Understanding the different types of non-invasive parenteral screening instruments is essential for market players to develop targeted strategies and products that cater to specific needs, ultimately driving the growth of the overall market.

Non-invasive Parenteral Screening Instruments Segmentation Breakdown9 items

Application

Diagnostic Laboratories

Hospitals

Types

Ultrasound Devices

Next-Generation Sequencing Systems

Polymerase Chain Reaction Instruments

Microarrays

Others

Regional Insights

Loading chart…

The Non-invasive Parenteral Screening Instruments market growth is anticipated to be driven by various regional factors. North America is the largest region, accounting for approximately 40% of the market share, driven by key drivers such as high adoption of advanced medical technologies, favorable policies supporting healthcare innovation, and significant investments in research and development. Europe is the second-largest region, with a share of around 30%, driven by factors such as a mature ecosystem, high demographics awareness, and a well-established infrastructure for healthcare services.

The fastest-growing region is Asia Pacific, with a projected regional forecast of 10% annual growth rate, driven by key drivers such as increasing demographics demand, improving infrastructure, and growing investments in healthcare technology. Latin America and Middle East & Africa are also expected to experience significant growth, with shares of around 15% and 15%, respectively, driven by factors such as rising adoption of non-invasive screening instruments, expanding ecosystem maturity, and government policies supporting healthcare development.

Competitive Landscape

The Non-invasive Parenteral Screening Instruments market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Non-invasive Parenteral Screening Instruments competitive landscape is characterized by high competition, with companies focusing on differentiation through product innovation and strategic partnerships.

Common strategies employed by key players include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must adapt to changing market dynamics and evolving customer needs.

GE Healthcare: regional expansion

Philips: premium pricing

Illumina: innovation pipeline

Thermo Fisher Scientific: OEM tie-ups

Roche: local manufacturing

PacBio: vertical integration

Key Non-invasive Parenteral Screening Instruments Companies10 items

GE Healthcare

Philips

Illumina

Thermo Fisher Scientific

Roche

PacBio

Perkinelmer

Qiagen

Agilent Technologies

BGI Group

Market Ecosystem

The Non-invasive Parenteral Screening Instruments ecosystem is a complex network of participants that create and capture value across the upstream, midstream, and downstream segments. Technology providers and suppliers deliver critical components, which are then integrated by manufacturers and system integrators. These solutions are subsequently distributed through various channels to end users, who ultimately drive adoption and demand. The ecosystem's boundaries are defined by the flow of value from technology development to end-user applications, with each segment influencing the next.

Raw material/component suppliers — provide essential components

OEMs / manufacturers — design and produce screening instruments

System integrators / EPCs — integrate instruments with other systems

Distributors / channel partners — deliver instruments to end users

Service providers / after-sales — offer maintenance and support services

End users / buyers — drive adoption and demand for screening instruments

Regulators/standards bodies — establish guidelines and approvals

The flow of value in the Non-invasive Parenteral Screening Instruments ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, including input constraints and interoperability requirements, can also affect the ecosystem's functioning. Furthermore, switching costs and partnerships between participants can limit flexibility and innovation. As the ecosystem differs by region, with varying standards and approvals, participants must navigate these complexities to succeed in the global market, necessitating a thorough value chain analysis to understand these dynamics.

Recent Industry Insights

The Non-invasive Parenteral Screening Instruments industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between leading medical device companies, have focused on enhancing the accuracy and reliability of non-invasive screening instruments. Furthermore, mergers and acquisitions have led to the expansion of product portfolios, enabling companies to cater to a broader range of customer needs.

Additionally, several product launches have taken place, incorporating cutting-edge technologies such as artificial intelligence and machine learning to improve the efficiency of non-invasive parenteral screening instruments. Regulatory changes have also played a crucial role in shaping the industry, with an increased emphasis on ensuring the safety and efficacy of these instruments. These developments have contributed to a shift in consumer and enterprise trends, with a growing preference for non-invasive screening methods.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Non-invasive Parenteral Screening Instruments market. The market attractiveness is high due to the increasing demand for non-invasive screening methods. The competitive intensity is moderate, with key players focusing on innovation and expansion. The long-term outlook for the Non-invasive Parenteral Screening Instruments market outlook is promising, driven by advancements in technology and growing awareness about the benefits of non-invasive screening.

The innovation landscape is rapidly evolving, with companies investing in research and development to improve the accuracy and efficiency of non-invasive screening instruments. However, the demand–supply balance is a key risk factor, as the market is subject to fluctuations in demand and supply chain disruptions. Overall, the Non-invasive Parenteral Screening Instruments market is expected to experience significant growth, driven by the increasing adoption of non-invasive screening methods in the healthcare industry.

12 items

1. Executive Summary

2. Non-invasive Parenteral Screening Instruments Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-invasive Parenteral Screening Instruments Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Non-invasive Parenteral Screening Instruments Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Non-invasive Parenteral Screening Instruments Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Non-invasive Parenteral Screening Instruments Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Non-invasive Parenteral Screening Instruments Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Non-invasive Parenteral Screening Instruments Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Non-invasive Parenteral Screening Instruments Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Non-invasive Parenteral Screening Instruments Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Non-invasive Parenteral Screening Instruments Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Non-invasive Parenteral Screening Instruments Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-invasive Parenteral Screening Instruments Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-invasive Parenteral Screening Instruments Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Non-invasive Parenteral Screening Instruments Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Non-invasive Parenteral Screening Instruments Market Competition by Key Manufacturers

9.1. Global Non-invasive Parenteral Screening Instruments Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Non-invasive Parenteral Screening Instruments: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GE Healthcare

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Philips

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Illumina

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Thermo Fisher Scientific

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Roche

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. PacBio

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Perkinelmer

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Qiagen

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Agilent Technologies

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. BGI Group

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-invasive Parenteral Screening Instruments Market

Figure 4: Global Non-invasive Parenteral Screening Instruments Market: Drivers

Figure 5: Global Non-invasive Parenteral Screening Instruments Market: Challenges

Figure 6: Global Non-invasive Parenteral Screening Instruments Market: Trends

Figure 7: Global Non-invasive Parenteral Screening Instruments Market: Opportunity

Figure 8: Global Non-invasive Parenteral Screening Instruments Market: Restraint

Figure 9: Global Non-invasive Parenteral Screening Instruments Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Non-invasive Parenteral Screening Instruments Market Value (USD Million) By Region

Figure 19: Global Non-invasive Parenteral Screening Instruments Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Non-invasive Parenteral Screening Instruments Market Value (USD Million) By Region

Figure 27: Global Non-invasive Parenteral Screening Instruments Market Share (%) By: Regions (2032)

Figure 28: Global Non-invasive Parenteral Screening Instruments Market Volume (K) By Region

Figure 29: Global Non-invasive Parenteral Screening Instruments Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Non-invasive Parenteral Screening Instruments Market Value (USD Million) By Region

Figure 37: Global Non-invasive Parenteral Screening Instruments Market Share (%) By: Regions (2032)

Figure 38: Global Non-invasive Parenteral Screening Instruments Market Volume (K) By Region

Figure 39: Global Non-invasive Parenteral Screening Instruments Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-invasive Parenteral Screening Instruments Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-invasive Parenteral Screening Instruments Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-invasive Parenteral Screening Instruments Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Non-invasive Parenteral Screening Instruments Market Value (USD Million) By Region

Table 14: Global Non-invasive Parenteral Screening Instruments Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Non-invasive Parenteral Screening Instruments Market Volume (K) By Region

Table 31: Global Non-invasive Parenteral Screening Instruments Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Non-invasive Parenteral Screening Instruments Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Non-invasive Parenteral Screening Instruments Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Non-invasive Parenteral Screening Instruments Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GE Healthcare Basic Information And Sales Area

Table 52: GE Healthcare. Products Portfolio

Table 53: Philips Basic Information And Sales Area

Table 54: Philips. Products Portfolio

Table 55: Illumina Basic Information And Sales Area

Table 56: Illumina. Products Portfolio

Table 57: Thermo Fisher Scientific Basic Information And Sales Area

Table 58: Thermo Fisher Scientific. Products Portfolio

Table 59: Roche Basic Information And Sales Area

Table 60: Roche. Products Portfolio

Table 61: PacBio Basic Information And Sales Area

Table 62: PacBio. Products Portfolio

Table 63: Perkinelmer Basic Information And Sales Area

Table 64: Perkinelmer. Products Portfolio

Table 65: Qiagen Basic Information And Sales Area

Table 66: Qiagen. Products Portfolio

Table 67: Agilent Technologies Basic Information And Sales Area

Table 68: Agilent Technologies. Products Portfolio

Table 69: BGI Group Basic Information And Sales Area

Table 70: BGI Group. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Non-invasive Parenteral Screening Instruments Market Value (USD Million) By Region

Table 80: Global Non-invasive Parenteral Screening Instruments Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Non-invasive Parenteral Screening Instruments Market Volume (K) By Region

Table 97: Global Non-invasive Parenteral Screening Instruments Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Non-invasive Parenteral Screening Instruments Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	12.87 million
Growth rate	CAGR of 0.065% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Philips; Illumina; Thermo Fisher Scientific; Roche; PacBio; Perkinelmer; Qiagen; Agilent Technologies; BGI Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Non-invasive Parenteral Screening Instruments Segmentation Breakdown9 items

Application

Diagnostic Laboratories

Hospitals

Types

Ultrasound Devices

Next-Generation Sequencing Systems

Polymerase Chain Reaction Instruments

Microarrays

Others

Regional Insights

Loading chart…

Competitive Landscape

GE Healthcare: regional expansion

Philips: premium pricing

Illumina: innovation pipeline

Thermo Fisher Scientific: OEM tie-ups

Roche: local manufacturing

PacBio: vertical integration

Key Non-invasive Parenteral Screening Instruments Companies10 items

GE Healthcare

Philips

Illumina

Thermo Fisher Scientific

Roche

PacBio

Perkinelmer

Qiagen

Agilent Technologies

BGI Group

Market Ecosystem

Raw material/component suppliers — provide essential components

OEMs / manufacturers — design and produce screening instruments

System integrators / EPCs — integrate instruments with other systems

Distributors / channel partners — deliver instruments to end users

Service providers / after-sales — offer maintenance and support services

End users / buyers — drive adoption and demand for screening instruments

Regulators/standards bodies — establish guidelines and approvals

Recent Industry Insights

Analyst Overview

Table of Contents